Table 3 Group median [Q1–Q3] of the APT effect per scan session and between-session COV per ROI per metric.

From: Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners

 

CE tumor (N = 6)

Tumor core (N = 3)

APT- weighted values in Session 1 (%)

APT- weighted values in Session 2 (%)

COV (%)

APT- weighted values in Session 1 (%)

APT- weighted values in Session 2 (%)

COV (%)

LD

6.61

[6.01–6.77]

7.04

[6.38–7.66]

4.57

[2.57–8.36]

5.88

[5.82–6.77]

5.92

[5.26–6.34]

5.67

[3.78–10.36]

MTRasym

1.53

[1.11–2.03]

1.35

[1.18–1.76]

9.20

[7.00–31.39]

2.06

[0.75–3.09]

1.37

[1.01–2.15]

8.93

[8.28–26.58]

MTRREX

19.24

[17.38–20.74]

18.56

[17.43–19.54]

3.89

[1.57–4.54]

18.96

[15.88–23.70]

15.05

[12.54–17.34]

9.78

[9.27–13.60]

  1. The COV of each participant was computed across two sessions performed on different days.
Back to article page